Hyaluronic acid-CD44 interaction mediates the adhesion of lymphocytes by amniotic membrane stroma

Cornea

Volumn 24, Issue 2, 2005, Pages 206-212

  Higa, Kazunari ^a   Shimmura, Shigeto ^a   Shimazaki, Jun ^a   Tsubota, Kazuo ^a  

^a TOKYO DENTAL COLLEGE   (Japan)

Author keywords

Amniotic membrane; Antiinflammatory; CD44; Cornea wound healing; Extracellular matrix adhesion; Hyaluronic acid

Indexed keywords

HYALURONIC ACID; HYALURONIDASE; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD44; TOLONIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACIDITY; AMNION; ARTICLE; CELL ADHESION; CONTROLLED STUDY; DRUG INHIBITION; ENZYME IMMUNOASSAY; EYE INJURY; FLOW CYTOMETRY; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LEUKEMIA CELL LINE; LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING;

ANTIGENS, CD44; CELL ADHESION; CELL LINE; CHROMATOGRAPHY, GEL; FEMALE; FLOW CYTOMETRY; HUMANS; HYALURONIC ACID; JURKAT CELLS; LIGANDS; LIPOPOLYSACCHARIDES; MONOCYTES; PYRAZOLES; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 14144252198     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000133999.45262.83     Document Type: Article

References (35)

1. Modesti A, Scarpa S, D'Orazi G, et al. Localization of type IV collagens in the stroma of human amnion. Prog Clin Biol Res. 1989;296:459-463.
2. Stern W. The grafting of preserved amniotic membrane to burned and ulcerated skin surfaces substituting skin grafts. JAMA. 1913;13:973-974.
3. Rotth AD. Plastic repair of conjunctival defect with fetal membranes. Arch Ophthalmol. 1940;23:522-525.
4. Lavery FS. Lime burn of conjunctiva and cornea treated with amnioplastin graft. Trans Ophthalmol Soc UK. 1946;66:668.
5. Sorsby A, Haythorne J, Reed H. Amniotic membrane grafts in caustic soda burns. Br J Ophthalmol. 1947;31:401-404.
6. Kim JC, Tseng SCG. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea. 1995;14:473-484.
7. Shimazaki J, Shinozaki N, Tsubota K. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br J Opthalmol. 1998;82:235-240.
8. Koizumi N, Inatomi T, Quantock AJ, et al. Amniotic membrane as a substrate for cultivating limbal corneal epithelial cells for autologous transplantation in rabbits. Cornea. 2000;19:65-71.
9. Lee SH, Tseng SC. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Opthalmol. 1997;123:303-312.
10. Tseng SC, Prabhasawat P, Lee S-H. Amniotic membrane transplantation for conjunctival surface reconstruction. Am J Ophthalmol. 1997;124:765-774.
11. Kim JS, Kim JC, Na BK, et al. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. Exp Eye Res. 2000;70:329-337.
12. Shimmura S, Shimazaki J, Ohashi Y, et al. Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea. 2001;20:408-413.
13. Sobolewski K, Bankowski E, Chyczewski L, et al. Collagen and glycosaminoglycans of Wharton's jelly. Biol Neonate. 1997;71:11-21.
14. Longaker MT, et al. Studies in fetal wound healing V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid. Ann Surg. 1991;213:292-296.
15. Deluise VP, Peterson WS. The use of topical Healon tears in the management of refractory dry-eye syndrome. Ann Ophthalmol. 1984;16:823-824.
16. Wysenbeek YS, Loya N, Ben SI, et al. The effect of sodium hyaluronate on the coreal epithelium. An ultrastructural study. Invest Ophthalmol Vis Sci. 1988;29:194-199.
17. Nishida T, Nakamura M, Mishima H, et al. Hyaluronan stimulates corneal epithelial migration. Exp Eye Res. 1991;53:753-758.
18. Inoue M, Katakami C. The effect of hyaluronic acid on corneal epithelial cell proliferation. Invest Ophthalmol Vis Sci. 1993;34:2313-2315.
19. Pearse AGE. Histochemistry, Theoretical & Applied, Vol I. London: J & A Churchill, 1968:70.
20. Spicer SS, Leppi TJ, Steward PJ. Suggestions for a histochemical terminology of carbohydrate-rich tissue components. J Histochem Cytochem. 1965;13:599-603.
21. Riessen R, Isner JM, Blessing E, et al. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol. 1994;144:962-974.
22. Meinert M, Eriksen GV, Peterson AC, et al. Proteoglycans and hyaluronan in human fetal membranes. Am J Obstet Gynecol. 2001;184:679-685.
23. Greenwald RA, Moy WW. Effect of oxygen-derived free radicals on hyaluronic acid. Arthritis Rheum. 1980;23:455-463.
24. Beck-Schimmer B, Oertli B, Pasch T, et al. Hyaluronan induces monocyte chemoatractant protein-1 expression in renal tubular epithelial cells. JAm Soc Nephrol. 1998;9:2283-2290.
25. Akatsuka M, Yamamoto Y, Tobetto K, et al. Suppresive effects of hyaluronic acid on elastase release from rat peritoneal leukocytes. J Pharm Pharmacol. 1993;45:110-114.
26. Polubinska A, Kuzlan-Pawlaczyk K, Pawlaczyk M, et al. Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats. Kidney Int. 2000;57:1182-1189.
27. 1. J Immunol. 2001;166:188-196.
28. Weyand CM, Goronzy JJ. Pathogenesis of rheumatoid arthritis. Med Clin North Am. 1997;81:29-55.
29. Hammer A, Blaschitz A, Daxbock C, et al. Fas and Fas-ligand are expressed in the uteroplacental unit of first-trimester pregnancy. Am J Reprod Immunol. 1999;41:41-51.
30. Hammer A, Dohr G. Expression of Fas-ligand in first trimester and term human placental villi. J Reprod Immunol. 2000;46:83-90.
31. Runic R, Lockwood C, LaChapelle L, et al. Apoptosis and Fas expression in human fetal membranes. J Clin Endocrinol Metab. 1998;83:660-666.
32. Runic R, Lockwood C, Ma Y, et al. Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J Clin Endocrinol Metab. 1996;81:3119-3122.
33. Ueta M, Kweon M, Sano Y, et al. Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction. Clin Exp Immunol. 2002;129:464-470.
34. Felli MP, Moschella C, Farina AR, et al. Prostaglandin E2 inhibits the interleukin-2 promoter activity through down-regulation of the Oct-dependent transcription of the octamer motif. Cell Immunol. 1996;172:229-234.
35. Riteau B, Menier C, Khalil-Daher I, et al. HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol. 1999;43:203-211.